1 free read left. Create a free account for unlimited reading + AI research.
Create free accountFinancial report
Remedy Entertainment
Remedy Entertainment’s business review for the first quarter of 2023 highlights a period of intensive investment as the company advances its multi-project development roadmap. The primary thesis centers on the transition toward a self-financed model for several key titles, which has temporarily impacted short-term profitability while positioning the firm for future royalty-based revenue growth. The company maintains its full-year outlook, anticipating a decline in revenue compared to the previous year and a negative operating result as it prioritizes long-term brand equity over immediate gains.
Financial performance for the quarter reflected the timing of project milestones, with revenue falling 45.4% to EUR 6.9 million compared to the same period in 2022. Consequently, the company reported an operating loss of EUR 5.6 million, down from an operating profit of EUR 2.8 million in the prior year. Despite these figures, the company maintains a solid balance sheet with an equity ratio of 89.1%. The workforce grew to 342 employees, supporting the development of five active projects, including the highly anticipated Alan Wake 2, which is currently in the final stages of full production.
The development portfolio is diverse, with projects such as Control 2, the multiplayer-focused Codename Condor, the free-to-play Codename Vanguard, and the Max Payne 1&2 remake all progressing through various stages of proof-of-concept or production. Management expects that as these titles reach the market and begin generating royalties, the current volatility in quarterly revenue and profitability will stabilize. The company continues to operate as a global entity headquartered in Finland, focusing on its proprietary Northlight engine to drive its story-driven, action-oriented game franchises.
Remedy Entertainment · 2024